The excretory capacity of the kidney for phosphorus is limited at relatively early stages of CKD despite the hormonal compensation of parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) [3,4,5], contributing to the elevation of serum phosphorus level (i.e., hyperphosphatemia). This evidence concerns the gene PTH and chronic kidney disease.